By Bloomberg 11/5/2013
“Testosterone replacement drugs, a $1.6 billion market for AbbVie Inc., Eli Lilly (LLY) & Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapies’ cardiovascular risk.”
Read the entire article: http://www.bloomberg.com/news/2013-11-05/testosterone-drugs-raise-heart-risk-in-1-billion-market.html
